KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 85 filers reported holding KALVISTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,263 | +15.7% | 131,147 | +8.1% | 0.01% | +75.0% |
| Q2 2023 | $1,092 | +930.2% | 121,353 | +671.3% | 0.01% | +700.0% |
| Q4 2022 | $106 | -100.0% | 15,734 | -5.0% | 0.00% | -66.7% |
| Q3 2022 | $240,000 | +46.3% | 16,557 | -0.8% | 0.00% | +50.0% |
| Q2 2022 | $164,000 | +3.8% | 16,691 | +39.6% | 0.00% | +100.0% |
| Q4 2021 | $158,000 | -49.7% | 11,956 | -33.6% | 0.00% | 0.0% |
| Q3 2021 | $314,000 | -43.2% | 17,998 | -22.1% | 0.00% | -66.7% |
| Q2 2021 | $553,000 | -4.0% | 23,090 | +3.0% | 0.00% | 0.0% |
| Q1 2021 | $576,000 | +453.8% | 22,412 | +309.3% | 0.00% | +200.0% |
| Q4 2020 | $104,000 | – | 5,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |